In re Da Vinci Surgical Robot Antitrust Litigation
featured news
February 26, 2014
General
Settlement With DaVita Healthcare Partners Shows Fraud Trend in Dialysis Industry
Over the next two posts, we will explore an increasing fraud trend affecting the dialysis industry. As more and more Americans become dialysis-dependent, the opportunity to take advantage of government programs like Medicare and Medicaid grows – thereby creating an epidemic of niche fraud resulting in hundreds of millions of […]
February 25, 2014
General
The IRC’s Whistleblower Provisions: How the Internal Revenue Service Catches Tax Fraud
The False Claims Act has been in existence since the Civil War era; however, it wasn’t until recently that other government agencies began to catch on to its effectiveness in catching and correcting fraud. In 2006, the Internal Revenue Service began implementing its own version of a whistleblower protection program […]
February 24, 2014
General
Government Settles With Kentucky-Based Addiction Center Under False Claims Act
One of the hallmark goals of the False Claims Act is to help eliminate fraud and wasteful healthcare spending, thereby reducing healthcare costs for all Americans. In a recent settlement under the False Claims Act, a Kentucky-area addiction center and two of its physicians were found to be engaging in […]
February 21, 2014
General
Pivotal Legal Issues Involved in Any False Claims Act Case
When a whistleblower plaintiff sets out to pursue her claim, she should begin by discussing the facts with a whistleblower attorney. If the claim seems likely to be meritorious, the attorney will file a complaint setting forth the facts and how the facts meet required legal thresholds. These thresholds are […]
February 20, 2014
General
Teva Pharmaceuticals Reveals Potential False Claims Act Liability in FY 2013 Report
Teva Pharmaceuticals, an Israeli-based drug maker, is at the mercy of the U.S. Department of Justice after allegations of False Claims Act violations surfaced late last year. The company is highly-respected for its Multiple Sclerosis and Parkinson’s Disease drugs, but has unfortunately been met with a subpoena for records pertaining […]featured investigations
$2.4B+
in 2025 post-trial judgments
$55B+
in Settlements & Verdicts
55+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated
